Skip to main content
. 2020 Aug 14;28(2):185–197. doi: 10.4103/ipj.ipj_3_19

Table 2.

Comparison of clinical variables in the three treatment groups

Clinical variables Treatment group Mean±SD df F P
Age (years) Lithium 15.33±1.72 2 0.28 0.756
Carbamazepine 15.40±1.50
Sodium valproate 15.70±1.75
Total number of past manic episode Lithium 0.16±0.46 2 1.71 0.188
Carbamazepine 0.30±0.732
Sodium valproate 0.52±0.79
Past number of depressive episodes Lithium 0.26±0.44 2 0.71 0.491
Carbamazepine 0.20±0.41
Sodium valproate 0.11±0.33
Duration of index episode (days) Lithium 48.93±54.45 2 0.44 0.643
Carbamazepine 34.90±36.19
Sodium valproate 48.11±70.90
Total number of episodes (including index episode) Lithium 1.43±0.67 2 0.59 0.556
Carbamazepine 1.40±0.75
Sodium valproate 1.64±0.86

df – Degree of freedom; P<0.05; F – ANOVA value. SD – Standard deviation